Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) Germany

Research

Date range: 1 September 2020 - 31 August 2021

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) published between 1 September 2020 - 31 August 2021 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)
Count Share
5 0.44

Outputs by subject (Share)

Outputs by subject
Subject Count Share
5 0.44
1 0.02

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
0.04 0.04 0.23 0.45 0.06

Compare Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) with other institutions

Collaboration

Date range: 1 September 2020 - 31 August 2021

  • 70.17% Domestic
  • 29.83% International

Note: Hover over the graph to view the percentage of collaboration.

International vs. domestic collaboration by Share


Top 10 domestic collaborators with Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) by Share (34 total)

  1. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Hannover Medical School (MHH) (1.75)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.44
    1.31
  2. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and The German Center for Lung Research (DZL) (0.61)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.44
    0.17
  3. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and CAPNETZ Stiftung (0.53)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.44
    0.09
  4. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Fraunhofer Society (0.53)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.44
    0.09
  5. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Leibniz University Hannover (LUH) (0.53)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.44
    0.09
  6. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Natural and Medical Sciences Institute (NMI) (0.43)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.04
    0.39
  7. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and RWTH Aachen University (RWTH Aachen) (0.42)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.29
    0.13
  8. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and 8sens.biognostic GmbH (0.42)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.29
    0.13
  9. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and University of Tübingen (Uni Tübingen) (0.31)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.04
    0.28
  10. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Max Planck Society (0.27)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.02
    0.24

Top 10 international collaborators with Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) by Share (21 total)

  1. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and UK Research and Innovation (UKRI) (0.73)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.09
    0.64
  2. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Institute of Health Carlos III (ISCIII) (0.36)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.29
    0.07
  3. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and European Commission (EC) (0.34)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.29
    0.06
  4. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Leiden University (0.34)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.29
    0.06
  5. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Duke University (0.21)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.11
    0.10
  6. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and University of Cambridge (0.18)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.09
    0.09
  7. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Cell Growth and Tissue Repair Laboratory (CRRET) (0.17)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.02
    0.15
  8. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and French National Centre for Scientific Research (CNRS) (0.11)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.02
    0.08
  9. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and Paris-Est Créteil University (UPEC) (0.10)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.02
    0.07
  10. Biomedical Research in Endstage and Obstructive Lung Disease (BREATH) and University of California, Los Angeles (UCLA) (0.09)
    Biomedical Research in Endstage and Obstructive Lung Disease (BREATH)0.04
    0.05